We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
The FDA has announced that it has approved the first single-dose flu drug with a novel mechanism of action in nearly two decades. The US regulator authorised Shionogi’s Xofluza (baloxavir marboxil)....